A cohort study found that patients diagnosed with diabetes at a younger age were more at risk for adverse outcomes when compared with later diagnosis.
Patients with diabetes who were diagnosed at a young age had a greater risk for heart disease, stroke, disability, cognitive impairment, and all-cause mortality, according to a study published in JAMA Network Open.
Diabetes is most prevalent in older adults, an expanding segment of the population of the United States. Older adults and middle-aged adults are treated similarly for diabetes, but it is unclear if this is the best course of action, as it’s possible the 2 age groups need to be treated differently due to differing adverse events. This study aimed to investigate 5 outcomes (heart disease, stroke, disability, cognitive impairment, and all-cause mortality) and compare their prevalence across age groups.
The analysis used the data from the 1995 to 2018 waves of the Health and Retirement Study (HRS). The respondents were from 6 HRS cohorts, including adults who lived in a community and those who were in nursing facilities. Respondents who self-reported incident diabetes with a diagnosis when they were aged 50 years or older were included whereas respondents who never reported diabetes acted as controls. Respondents were excluded if they had missing age data, were younger than 50 years, missing self-reported diabetes information, reported diabetes at the baseline HRS interview, had 1 of the outcomes before their diagnosis of diabetes, or had missing data for that outcome.
The analysis included 36,034 respondents, of which 7739 had self-reported incident diabetes. There were 1866 respondents who had a diagnosis at 50 to 59 years, 2834 at 60 to 69 years, and 3039 at 70 years or older. There were 4267 (55.1%) women in this cohort and the mean (SD) age of the population was 67.42 (9.88) years, with a mean follow-up of 20 (IQR, 8-26) years.
Respondents aged 70 years and older at diagnosis were more likely to be male (45.5% vs 38.6%), non-Hispanic White (73.7% vs 49.9%), not married (47.1% vs 26.3%), and have less educational attainment (less than 12 years, 28.5% vs 39.7%) and wealth (less than $40,000, 75.2% vs 52.6%) compared with the group aged 50 to 59 at diagnosis.
Adults who were older at diagnosis also had a lower median body mass index (27.4 [IQR, 24.3-30.9] vs 31.3 [IQR, 27.4-35.9]), less smoking (6.4% vs 19.9%), and a higher prevalence of comorbid conditions (heart disease, 44.4% vs 20.7%; disability, 8.8% vs 1.9%) compared with those aged 50 to 59 years at diagnosis.
The incident rate ratio (IRR) of heart disease between each diabetes group and their matched control group decreased as the age at diagnosis of diabetes increased. The IRRs were 1.69 (95% CI, 1.42-2.02) for those aged 50 to 59 years, 1.24 (95% CI, 1.08-1.41) for those aged 60 to 69 years, and 1.16 (95% CI, 1.00-1.35) for those aged 70 years and older at the time of diagnosis.
Respondents who were diagnosed with diabetes aged 50 to 59 years had a higher incidence of stroke (IRR, 1.70; 95% CI, 1.34-2.15), disability (IRR, 2.03; 95% CI, 1.55-2.66), and mortality (IRR, 1.43; 95% CI, 1.24-1.65) compared with their matched controls. Respondents who were diagnosed with diabetes aged 60 to 69 years had a significantly higher incidence of stroke (IRR, 1.39; 95% CI, 1.15-1.67) and disability (IRR, 1.29; 95% CI, 1.07-1.55) compared to their matched control, although the IRR was lower than for those aged 50 to 59 years at the time of diagnosis.
Diabetes was also associated with an elevated risk of heart disease (HR, 1.66; 95% CI, 1.40-1.96), stroke (HR, 1.64; 95% CI, 1.30-2.07), disability (HR, 2.08; 95% CI, 1.59-2.72), cognitive impairment (HR, 1.30; 95% CI, 1.05-1.61), and mortality (HR, 1.49; 95% CI, 1.29-1.71) for those who were diagnosed with diabetes aged 50 to 59 years compared with their matched control. Diabetes was only associated with elevated mortality (HR, 1.08; 95% CI, 1.01-1.17) for those aged 70 years and older when diagnosed.
There were some limitations to this study. Measurement errors could not be ruled out due to the self-reporting of diabetes in the respondents. Self-reported diabetes also could distinguish between the 2 types of diabetes. Matched controls may be subjected to ascertainment bias because of the shorter follow-up for reporting diabetes. The impact of prediabetes was not explored in this study.
The researchers concluded that the association of diabetes with incident distal outcomes varied by the age of diagnosis, with those younger at time of diagnosis more susceptible to adverse outcomes when compared with those who are diagnosed at a later age.
Reference
Cigolle CT, Blaum CS, Lyu C, Ha J, Kabeto M, Zhong J. Associations of age at diagnosis and duration of diabetes with morbidity and mortality among older adults. JAMA Netw Open. 2022;5(9):e2232766. doi:10.1001/jamanetworkopen.2022.32766.
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout
February 22nd 2024More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.
Read More
Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations
February 15th 2024Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.
Read More